EGFR and lung adenocarcinoma: In Epidermal Growth Factor Receptor (EGFR)-mutated lung adenocarcinoma, we previously reported on surgical samples that TWIST1 expression was linked to EGFR mutations, low E-cadherin expression and low disease-free survival [44].